Ground Swell Capital, LLC has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity securities holdings as of the close of business on September 30, 2026. The filing, signed by Chief Compliance Officer Joey Foxhall on November 9, 2026, lists a total of 144 securities held by the firm.
The portfolio includes a mix of large-cap technology companies, healthcare firms, and exchange-traded funds. Notable positions include shares in 10x Genomics Inc., Amazon.com Inc., Advanced Micro Devices Inc., and Apple Inc. The firm also holds significant positions in biotechnology companies such as Arbor BioPharma Corp., Arcturus Therapeutics Holdings Inc., and Immunovant Inc.
Exchange-traded funds represent a substantial portion of the portfolio. The filing lists holdings in iShares Core S&P 500 ETF, iShares Core U.S. Aggregate Bond ETF, and various other bond and sector-specific ETFs. Additionally, the firm holds shares in companies across diverse sectors including energy, such as Chord Energy Corporation, and consumer staples, such as Krispy Kreme Inc.
